-
DBV Technologies S.A (DBVT) PT Raised to $45 at Citizens
-
DBV Technologies S.A (DBVT) PT Raised to $51 at Guggenheim
-
DBV Technologies S.A (DBVT) PT Raised to $35 at H.C. Wainwright
-
Cantor Fitzgerald Starts DBV Technologies S.A (DBVT) at Overweight
-
Guggenheim Starts DBV Technologies S.A (DBVT) at Buy
-
DBV Technologies sells $30 million of shares through ATM program
-
Citizens JMP Reiterates Market Outperform Rating on DBV Technologies S.A (DBVT)
-
Citizens JMP Reiterates Market Outperform Rating on DBV Technologies S.A (DBVT)
-
Goldman Sachs Reinstates DBV Technologies S.A (DBVT) at Sell
-
Goldman Sachs Reinstates DBV Technologies S.A (DBV:FP) (DBVT) at Sell
-
DBV Technologies S.A (DBVT) PT Raised to $21 at Citizens JMP
-
DBV Technologies S.A (DBVT) PT Raised to $16 at H.C. Wainwright
-
DBV Technologies (DBVT) Misses Q1 EPS by 26c
-
Citizens JMP Reiterates Market Outperform Rating on DBV Technologies S.A (DBVT)
-
Citizens JMP Reiterates Market Outperform Rating on DBV Technologies S.A (DBVT)
-
JMP Securities Reiterates Market Outperform Rating on DBV Technologies S.A (DBVT)
-
DBV Technologies (DBVT) Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
-
DBV Technologies (DBVT) Misses Q3 EPS by 32c
-
DBV Technologies S.A (DBVT) PT Raised to $7 at H.C. Wainwright

